ROTATEQ™ Post-Marketing Surveillance in the Philippines

Merck Sharp & Dohme (MSD)

Status: Terminated

Conditions: Rotavirus Infections; Gastroenteritis

Study type: Observational

Funder types: Industry

Identifiers

NCT01357174

V260-046

Details and patient eligibility

About

This study will collect demographic and safety information on the use of ROTATEQ™ in the Philippines.

Enrollment: 915 patients

Sex: All

Ages: 6 to 12 weeks old

Volunteers: Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• Received ROTATEQ™

Trial design

915 participants in 1 patient group

All Participants

Description:

Infants who were vaccinated with ROTATEQ™